Skip to main content

Advertisement

Log in

Supratarsal injection of triamcinolone acetonide and childhood allergic keratoconjunctivitis

  • Original Paper
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

To evaluate the efficacy and safety of supratarsal injection of triamcinolone acetonide in the treatment of refractory allergic keratoconjunctivitis in childhood. Thirty-five patients (70 eyes) with severe allergic keratoconjunctivitis were included in this study. Fifteen patients (42.8%) had atopic keratoconjunctivitis (AKC) and 20 (57.2%) had vernal keratoconjuncivitis (VKC). All patients underwent a bilateral supratarsal injection of 20 mg triamcinolone acetonide. Mean follow-up was 28 months (range 14–38). All patients showed a significant symptomatic improvement and partial resolution of clinical features of keratoconjunctivitis within the first 2 weeks. Corneal complications related to keratoconjunctivitis disappeared in all patients. One patient with VKC experienced ocular hypertension. No patient with AKC showed side-effects. Severe relapse of the disease was noted in 10% of eyes with VKC and in 6.7% of eyes with AKC after a mean follow-up of 9 and 11 months, respectively. Supratarsal injection of triamcinolone acetonide is effective and safe in patients with severe chronic allergic keratoconjunctivits to relieve severe inflammation associated with this disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Leonardi A, De Dominicis C, Motterle L (2007) Immunopathogenesis of ocular allergy: a schematic approach to different clinical entities. Curr Opin Allergy Clin Immunol 7:429–435

    Article  PubMed  CAS  Google Scholar 

  2. Guglielmetti S, Dart JK, Calder V (2010) Atopic keratoconjunctivitis and atopic dermatitis. Curr Opin Allergy Clin Immunol 10:478–485

    Article  PubMed  CAS  Google Scholar 

  3. Bonini S, Sacchetti M, Mantelli F et al (2007) Clinical grading of vernal keratoconjunctivitis. Curr Opin Allergy Clin Immunol 7:436–441

    Article  PubMed  Google Scholar 

  4. Calonge M, Herreras JM (2007) Clinical grading of atopic keratoconjunctivitis. Curr Opin Allergy Clin Immunol 7:442–445

    Article  PubMed  Google Scholar 

  5. Bonini S, Bonini S, Lambiase A et al (2000) Vernal keratoconjunctivitis revisited: a case series of 195 patients with long-term follow-up. Ophthalmology 107:1157–1163

    Article  PubMed  CAS  Google Scholar 

  6. Kumar S (2009) Vernal keratoconjunctivitis: a major review. Acta Ophthalmol 87:133–147

    Article  PubMed  CAS  Google Scholar 

  7. Keklikci U, Soker SI, Sakalar YB et al (2008) Efficacy of topical cyclosporin A 0.05% in conjunctival impression cytology specimens and clinical findings of severe vernal keratoconjunctivitis in children. Jpn J Ophthalmol 52:357–362

    Article  PubMed  CAS  Google Scholar 

  8. Ozcan AA, Ersoz TR, Dulger E (2007) Management of severe allergic conjunctivitis with topical cyclosporin A 0.05% eyedrops. Cornea 26:1035–1038

    Article  PubMed  Google Scholar 

  9. Bellini LP, Bulla MC, Brum GS (2008) Topical cyclosporin A in severe allergic conjunctivitis. Cornea 27:625

    Article  PubMed  Google Scholar 

  10. Stumpf T, Luqmani N, Sumich P, Cook S, Tole D (2006) Systemic tacrolimus in the treatment of severe atopic keratoconjunctivitis. Cornea 25:1147–1149

    Article  PubMed  Google Scholar 

  11. Holsclaw DS, Whitcher JP, Wong IG et al (1996) Supratarsal injection of corticosteroid in the treatment of refractory vernal keratoconjunctivitis. Am J Ophthalmol 121:243–249

    PubMed  CAS  Google Scholar 

  12. Saini JS, Gupta A, Pandey SK et al (1999) Efficacy of supratarsal dexamethasone versus triamcinolone injection in recalcitrant vernal keratoconjunctivitis. Acta Ophthalmol Scand 77:515–518

    Article  PubMed  CAS  Google Scholar 

  13. Singh S, Pal V, Dhull CS (2001) Supratarsal injection of corticosteroids in the treatment of refractory vernal keratoconjunctivitis. Indian J Ophthalmol 49:241–245

    PubMed  CAS  Google Scholar 

  14. Sacchetti M, Baiardini I, Lambiase A et al (2007) Development and testing of the quality of life in children with vernal keratoconjunctivitis questionnaire. Am J Ophthalmol 144:557–563

    Article  PubMed  Google Scholar 

  15. Rouher N, Pilon F, Dalens H et al (2004) Implantation of preserved human amniotic membrane for the treatment of shield ulcers and persistent corneal epithelial defects in chronic allergic keratoconjunctivitis. J Fr Ophtalmol 27:1091–1097

    Article  PubMed  CAS  Google Scholar 

  16. Shen YC, Wang CY, Tsai HY et al (2007) Supratarsal triamcinolone injection in the treatment of superior limbic keratoconjunctivitis. Cornea 26:423–426

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Moncef Khairallah.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zaouali, S., Kahloun, R., Attia, S. et al. Supratarsal injection of triamcinolone acetonide and childhood allergic keratoconjunctivitis. Int Ophthalmol 32, 99–106 (2012). https://doi.org/10.1007/s10792-011-9421-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-011-9421-4

Keywords

Navigation